Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients

Foley, 1998, Epidemiology of cardiovascular disease in chronic renal disease., J Am Soc Nephrol, 9, S16 Witztum, 2001, The oxidative modification hypothesis of atherosclerosis: does it hold for humans?, Trends Cardiovasc Med, 11, 93, 10.1016/S1050-1738(01)00111-6 Harrison, 2003, Role of oxidative stress in atherosclerosis., Am J Cardiol, 91, 7A, 10.1016/S0002-9149(02)03144-2 Himmelfarb, 2002, The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia., Kidney Int, 62, 1524, 10.1046/j.1523-1755.2002.00600.x Morena, 2002, Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients., Nephrol Dial Transplant, 17, 422, 10.1093/ndt/17.3.422 Ward, 1995, Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency., J Am Soc Nephrol, 5, 1697, 10.1681/ASN.V591697 Morena, 2005, Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation., Hemodial Int, 9, 37, 10.1111/j.1492-7535.2005.01116.x Miyazaki, 2000, Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer., Circulation, 101, 1002, 10.1161/01.CIR.101.9.1002 Tsuruoka, 2002, Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure., Am J Kidney Dis, 39, 127, 10.1053/ajkd.2002.29901 Shimazu, 2001, Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production., Kidney Int Suppl, 78, S137, 10.1046/j.1523-1755.2001.59780137.x Morimoto, 2005, Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients., Nephrol Dial Transplant, 20, 2775, 10.1093/ndt/gfi121 Itabe, 1996, Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody., J Lipid Res, 37, 45, 10.1016/S0022-2275(20)37634-3 Holvoet, 1996, Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure., Thromb Haemost, 76, 663, 10.1055/s-0038-1650639 Van Tits, 2003, Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis., Lab Invest, 83, 13, 10.1097/01.LAB.0000048633.76607.E0 Fortuño, 2006, Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome., Diabetes, 55, 209, 10.2337/diabetes.55.01.06.db05-0751 Guzik, 2000, Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors., Circ Res, 86, E85 Fortuño, 2005, Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease., Kidney Int Suppl, 99, S71, 10.1111/j.1523-1755.2005.09913.x Islam, 2000, Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy., Atherosclerosis, 150, 217, 10.1016/S0021-9150(99)00410-4 Boaz, 2000, Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial., Lancet, 356, 1213, 10.1016/S0140-6736(00)02783-5 Hollman, 1997, Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man., FEBS Lett, 418, 152, 10.1016/S0014-5793(97)01367-7 Aviram, 2002, Wine flavonoids protect against LDL oxidation and atherosclerosis., Ann N Y Acad Sci, 957, 146, 10.1111/j.1749-6632.2002.tb02913.x Arts, 2005, Polyphenols and disease risk in epidemiologic studies., Am J Clin Nutr, 81, 317S, 10.1093/ajcn/81.1.317S Zern, 2005, Cardioprotective effects of dietary polyphenols., J Nutr, 135, 2291, 10.1093/jn/135.10.2291 Ying, 2003, Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells., Hypertens Res, 26, 823, 10.1291/hypres.26.823 Sánchez, 2006, Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats., J Hypertens, 24, 75, 10.1097/01.hjh.0000198029.22472.d9 Sarr, 2006, Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase., Cardiovasc Res, 71, 794, 10.1016/j.cardiores.2006.05.022 Freedman, 2001, Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release., Circulation, 103, 2792, 10.1161/01.CIR.103.23.2792 O'Byrne, 2002, Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults., Am J Clin Nutr, 76, 1367, 10.1093/ajcn/76.6.1367 Zern, 2005, Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress., J Nutr, 135, 1911, 10.1093/jn/135.8.1911 Castilla, 2006, Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects., Am J Clin Nutr, 84, 252, 10.1093/ajcn/84.1.252 Dávalos, 2006, Red grape juice polyphenols alter cholesterol homeostasis and increase LDL-receptor activity in human cells in vitro., J Nutr, 136, 1766, 10.1093/jn/136.7.1766 Ortega, 2004, Liquid chromatographic method for the simultaneous determination of different lipid-soluble antioxidants in human plasma and low-density lipoproteins., J Chromatogr B Analyt Technol Biomed Life Sci, 803, 249, 10.1016/j.jchromb.2003.12.025 Bass, 1983, Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation., J Immunol, 130, 1910, 10.4049/jimmunol.130.4.1910 Richardson, 1998, A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test., J Immunol Methods, 219, 187, 10.1016/S0022-1759(98)00136-7 Tauber, 1984, Flavonoid inhibition of the human neutrophil NADPH-oxidase., Biochem Pharmacol, 33, 1367, 10.1016/0006-2952(84)90194-1 Pignatelli, 2006, Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine., Atherosclerosis, 188, 77, 10.1016/j.atherosclerosis.2005.10.025 Al-Awwadi, 2005, Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats., J Agric Food Chem, 53, 151, 10.1021/jf048919f Bub, 2001, Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice., Eur J Nutr, 40, 113, 10.1007/s003940170011 Dávalos, 2006, Quercetin is bioavailable from a single ingestion of grape juice., Int J Food Sci Nutr, 57, 391, 10.1080/09637480600858662 Venugopal, 2002, Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha., Diabetes, 51, 3049, 10.2337/diabetes.51.10.3049 Cachia, 1998, alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation., J Biol Chem, 273, 32801, 10.1074/jbc.273.49.32801 Calvisi, 2004, Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer., J Hepatol, 41, 815, 10.1016/j.jhep.2004.07.030 Fraley, 2006, Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease., Curr Opin Lipidol, 17, 502, 10.1097/01.mol.0000245255.40634.b5 Holvoet, 1998, Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease., Circulation, 98, 1487, 10.1161/01.CIR.98.15.1487 Ehara, 2001, Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes., Circulation, 103, 1955, 10.1161/01.CIR.103.15.1955 Tsimikas, 2005, Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease., N Engl J Med, 353, 46, 10.1056/NEJMoa043175 Holvoet, 2001, Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease., Arterioscler Thromb Vasc Biol, 21, 844, 10.1161/01.ATV.21.5.844 Nishi, 2002, Oxidized LDL in carotid plaques and plasma associates with plaque instability., Arterioscler Thromb Vasc Biol, 22, 1649, 10.1161/01.ATV.0000033829.14012.18 Liu, 2004, Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families., Arterioscler Thromb Vasc Biol, 24, 1492, 10.1161/01.ATV.0000135982.60383.48 Nordin Fredrikson, 2003, Plasma oxidized LDL: a predictor for acute myocardial infarction?, J Intern Med, 253, 425, 10.1046/j.1365-2796.2003.01128.x Shimada, 2004, Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease., Diabetes Care, 27, 843, 10.2337/diacare.27.3.843 Meisinger, 2005, Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population., Circulation, 112, 651, 10.1161/CIRCULATIONAHA.104.529297 Braun, 2005, Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting., Am Heart J, 150, 550, 10.1016/j.ahj.2004.10.008 Wu, 2006, Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?, J Am Coll Cardiol, 48, 973, 10.1016/j.jacc.2006.03.057 Carrero, 1998, Flavonoid-induced ability of minimally modified low-density lipoproteins to support lymphocyte proliferation., Biochem Pharmacol, 55, 1125, 10.1016/S0006-2952(97)00635-7 Hayek, 1997, Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation., Arterioscler Thromb Vasc Biol, 17, 2744, 10.1161/01.ATV.17.11.2744 Fuhrman, 1995, Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation., Am J Clin Nutr, 61, 549, 10.1093/ajcn/61.3.549 Pal, 2003, Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells., J Nutr, 133, 700, 10.1093/jn/133.3.700 Kusano, 2004, Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis., Circ J, 68, 671, 10.1253/circj.68.671 Feng, 1999, Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits., Circulation, 100, 2254, 10.1161/01.CIR.100.22.2254 Badía, 2004, Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption., Am J Clin Nutr, 80, 225, 10.1093/ajcn/80.1.225 Satriano, 1993, Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G., Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest, 92, 1564 Jacobson, 2000, Three monocyte-related determinants of atherosclerosis in haemodialysis., Nephrol Dial Transplant, 15, 1414, 10.1093/ndt/15.9.1414